Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059926
Filing Date
2024-05-15
Accepted
2024-05-14 19:34:46
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20240331.htm   iXBRL 10-Q 1228924
2 EX-2.1 cvsi-ex2_1.htm EX-2.1 351496
3 EX-31.1 cvsi-ex31_1.htm EX-31.1 13949
4 EX-31.2 cvsi-ex31_2.htm EX-31.2 13319
5 EX-32.1 cvsi-ex32_1.htm EX-32.1 6369
6 EX-32.2 cvsi-ex32_2.htm EX-32.2 6357
  Complete submission text file 0000950170-24-059926.txt   6383582

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20240331.xsd EX-101.SCH 1034287
77 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20240331_htm.xml XML 861758
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 24946539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)